Saingga, Genevie .
HRN: 26-96-96 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2025
CEFUROXIME 1.5GM (VIAL)
05/18/2025
05/19/2025
IV
1.5gms
Q8hrs
S/P VBAC; 2nd Degree Perineal Laceration
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes